| 5K3Y: reference: Pharmacological Profile of BI 847325, an Orally Bioavailable, ATP-competitive Inhibitor of MEK and Aurora Kinases., Sini P, Gurtler U, Zahn SK, Baumann C, Rudolph D, Baumgartinger R, Strauss E, Haslinger C, Tontsch-Grunt U, Waizenegger IC, Solca F, Bader G, Zoephel A, Treu M, Reiser U, Garin-Chesa P, Boehmelt G, Kraut N, Quant J, Adolf GR, Mol Cancer Ther. 2016 Aug 5. pii: molcanther.0066.2016. PMID: 27496137 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).